MedTrace Logo

Rapid Biochemical Diagnostics of Traumatic Brain Injury

NCT03306563 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 68

Last updated 2021-06-08

No results posted yet for this study

Summary

The objective of the study is to confirm the clinical relevance of the novel biomarker for traumatic brain injury (TBI) detection. Samples of blood, urine and saliva will be collected from a) patients with suspected TBI (isolated), b) patients with orthopedic injury, and c) healthy controls. The sponsor will do biochemical investigations for the samples to evaluate the presence, level and structure of the targeted biomarker.

Conditions

Interventions

DIAGNOSTIC_TEST

Sample collection

Samples of blood, urine and saliva will be collected at up to five successive time points.

Sponsors & Collaborators

  • Medicortex Finland Oy

    lead INDUSTRY

Principal Investigators

  • Mårten Kvist, MD/PhD · Medicortex Finland Oy

Study Design

Allocation
NON_RANDOMIZED
Purpose
DIAGNOSTIC
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-12-28
Primary Completion
2019-01-23
Completion
2021-06-07

Countries

  • Finland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03306563 on ClinicalTrials.gov